SubscribeIn the News

JUVENTAS THERAPEUTICS ADDS $13.5 MILLION IN NEW FINANCING AND EXPANDS BOARD OF DIRECTORS

Tuesday, May 12th, 2015 | Healthcare

AKEBIA THERAPEUTICS ANNOUNCES CLOSING OF PUBLIC OFFERING AND FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

Wednesday, April 22nd, 2015 | Healthcare

OXFORD FINANCE AND SILICON BANK CLOSE $12 MILLION SENIOR CREDIT FACILITY WITH RESHAPE MEDICAL

Tuesday, April 21st, 2015 | Healthcare

CHROMATIN: SORGHUM PARTNERS ANNOUNCES SUGARCANE APHID INTEGRATED PEST MANAGEMENT PROGRAM

Thursday, April 16th, 2015 | Clean Tech

CELLECTAR BIOSCIENCES INITIATES PROOF-OF-CONCEPT TRIAL OF I-131-CLR1404 IN MULTIPLE MYELOMA

Wednesday, April 15th, 2015 | Healthcare

ALFALIGHT: HIGH-POWER LASER SPINOFF PROVES VERSATILITY IS STRENGTH

Monday, April 13th, 2015 | Clean Tech

FDA SAYS RESHAPE MEDICAL CAN SKIP ADVISORY PANEL FOR OBESITY BALLOON DEVICE

Tuesday, April 7th, 2015 | Healthcare

CELLECTAR BIOSCIENCES: READY, AIM, FIRE! CANCER-TARGETING MECHANISM UNDERLIES PROMISING UW-MADISON SPINOFF

Monday, March 30th, 2015 | Healthcare

MIST THERAPY DEMONSTRATES BETTER HEALING AND REDUCED RECIDIVISM IN SPLIT THICKNESS DONOR SITE RANDOMIZED CONTROLLED TRIAL

Thursday, March 26th, 2015 | Healthcare

CHROMATIN SORGHUM HYBRIDS PRODUCE FIVEFOLD YIELD INCREASE IN EAST AFRICA

Wednesday, March 18th, 2015 | Clean Tech

AKEBIA ANNOUNCES PRESENTATION OF RESULTS FROM ITS PHASE 2B STUDY OF AKB-6548 IN NON-DIALYSIS PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE AT THE INTERNATIONAL SOCIETY OF NEPHROLOGY’S WORLD CONGRESS OF NEPHROLOGY

Monday, March 16th, 2015 | Healthcare

AKEBIA TRIAL SHOWS ANEMIA DRUG SPURS “CONTROLLED” RESPONSE

Monday, March 16th, 2015 | Healthcare

MADISON VACCINES EXPANDS INVESTIGATIONAL PROSTATE CANCER VACCINES

Thursday, March 12th, 2015 | Healthcare

MADISON VACCINES EXPANDS SERIES A TO ADVANCE PROSTATE CANCER DRUGS

Tuesday, March 10th, 2015 | Healthcare

HEALTHMYNE RAISES $4.5M IN SERIES A ROUND OF VENTURE CAPITAL FINANCING

Tuesday, March 10th, 2015 | Technology

AKEBIA ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2 TRIAL OF AKB-6548 IN DIALYSIS PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE

Tuesday, March 10th, 2015 | Healthcare

AERPIO THERAPEUTICS ANNOUNCES PUBLICATION OF POSITIVE RESULTS OF PHASE 1B/2A CLINICAL TRIAL OF NOVEL TIE2 ACTIVATOR, AKB-9778, FOR THE TREATMENT OF PATIENTS WITH DIABETIC MACULAR EDEMA (DME) – TIME-1 STUDY

Wednesday, March 4th, 2015 | Healthcare

CHROMATIN EXPANDS ITS EXECUTIVE TEAM

Thursday, February 26th, 2015 | Clean Tech

CHROMATIN, INC. ANNOUNCES PRODUCTION OF FARNESENE IN SORGHUM

Wednesday, February 25th, 2015 | Clean Tech

CHROMATIN: SORGHUM PARTNERS BRINGS MARKET LEADING HYBRIDS TO NORTH CAROLINA

Thursday, February 19th, 2015 | Clean Tech

NEUWAVE MEDICAL: EXERGEN GLOBAL’S TEMPERATURE SENSOR ENSURES SAFETY, EFFICIENCY FOR ABLATION SYSTEMS

Wednesday, February 18th, 2015 | Healthcare

CHROMATIN EXPANDING ITS PRESENCE IN THE REGION

Wednesday, February 11th, 2015 | Clean Tech

ALLIQUA BIOMEDICAL, INC. TO ACQUIRE CELLERATION, INC.

Monday, February 2nd, 2015 | Healthcare

VENTURE INVESTORS’ PORTFOLIO COMPANY, TISSUE REGENERATION SYSTEMS (TRS), COLLABORATION WITH JOHNSON & JOHNSON VIDEO

Friday, January 30th, 2015 | Healthcare

VENTURE INVESTORS: MICHIGAN VENTURE CAPITAL INVESTMENT VALUE UP NEARLY 100% FROM 2013

Wednesday, January 28th, 2015 | Venture Investors

CELLERATION, INC. ANNOUNCES STATISTICALLY SIGNIFICANT BETTER HEALING WITH MIST THERAPY IN THE IN-BALANCE VLU RANDOMIZED CONTROL TRIAL

Tuesday, January 27th, 2015 | Healthcare

ALFALIGHT RECEIVES $1.9M RAYTHEON CONTRACT TO DELIVER LASER SUBSYSTEMS FOR AEROSPACE APPLICATION

Thursday, January 22nd, 2015 | Clean Tech

COKE’S PLANT BOTTLE – COCA COLA INVESTS FURTHER IN SCALING VIRENT’S PARAXYLENE PRODUCTION

Thursday, January 22nd, 2015 | Clean Tech

PEER-REVIEWED GLIOMA SURGERY STUDY WITH CELLECTAR BIOSCIENCES FLUORESCENCE CANCER-TARGETING AGENTS CHOSEN FOR THE COVER OF NEUROSURGERY

Thursday, January 22nd, 2015 | Healthcare

UPTO INTROS PLUGIN FOR CHROME, BRINGS FEATURES TO GOOGLE CALENDAR

Thursday, January 15th, 2015 | Technology

TISSUE REGENERATION SYSTEMS ADDS BUSINESS DEVELOPMENT EXECUTIVE

Wednesday, January 14th, 2015 | Healthcare

SILATRONIX: UW GRANT PROGRAM SEEDS PROMISING IDEAS, LIKE SAFER BATTERIES

Thursday, January 8th, 2015 | Clean Tech

AKEBIA COMPLETES ENROLLMENT IN THE TWO PLANNED COHORTS OF ITS PHASE 2 STUDY OF AKB-6548 IN PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS

Monday, January 5th, 2015 | Healthcare

HISTOSONICS: UNIVERSITIES PUSH HARDER INTO REALM OF STARTUPS

Wednesday, December 17th, 2014 | Healthcare

WISCONSIN STILL MISSING AN INGREDIENT IN THE START-UP STEW

Wednesday, December 17th, 2014 | Venture Investors

AKEBIA THERAPEUTICS, INC. ADDED TO NASDAQ BIOTECHNOLOGY INDEX

Monday, December 15th, 2014 | Healthcare

NEUROVANCE ANNOUNCES TOP-LINE STUDY RESULTS SUGGEST LOWER ABUSE POTENTIAL FOR CENTANAFADINE COMPARED TO STIMULANTS USED FOR ADULT ADHD

Thursday, December 11th, 2014 | Healthcare

VIRENT ANNOUNCES WORLD’S FIRST DEMONSTRATION OF FULL RANGE BIO-AROMATICS PRODUCTION

Thursday, December 11th, 2014 | Clean Tech

AERPIO THERAPEUTICS COMPLETES ENROLLMENT OF PHASE 2 STUDY OF TIE2 ACTIVATOR AKB-9778 FOR THE TREATMENT OF PATIENTS WITH DIABETIC MACULAR EDEMA

Thursday, December 4th, 2014 | Healthcare

CELLECTAR BIOSCIENCES GRANTED ORPHAN DESIGNATION FOR I-131-CLR1404 FOR THE TREATMENT OF MULTIPLE MYELOMA

Thursday, December 4th, 2014 | Healthcare

CHROMATIN: SORGHUM PARTNERS SORGHUM HYBRIDS DEMONSTRATE TOLERANCE AGAINST SUGARCANE APHIDS

Thursday, December 4th, 2014 | Clean Tech

RESHAPE MEDICAL: A BALLOON MAY AID WEIGHT LOSS

Thursday, November 27th, 2014 | Healthcare

CELLECTAR BIOSCIENCES NAMES CAMERON SZAKACS, PH.D. VICE PRESIDENT OF CLINICAL DEVELOPMENT

Tuesday, November 25th, 2014 | Healthcare

VIRENT: SHELL EXPECTS TO BE PRODUCING ADVANCED BIOFUELS AT SCALE, IN US, BY END OF DECADE

Monday, November 24th, 2014 | Clean Tech

RESHAPE MEDICAL: A BALLOON FOR OBESITY – AN OPTION BETWEEN MEDICATION AND SURGERY?

Monday, November 24th, 2014 | Healthcare

CHROMATIN: TECHAG DEMONSTRATES EXCEPTIONAL PERFORMANCE OF SORGHUM PARTNERS HYBRID SORGHUM PRODUCTS IN MEXICO

Wednesday, November 19th, 2014 | Clean Tech

JUVENTAS THERAPEUTICS PRESENTS PHASE II DATA AT AHA SCIENTIFIC SESSIONS THAT SHOWS JVS-100 IS SAFE, POTENTIALLY EFFECTIVE IN PATIENTS WITH CRITICAL LIMB ISCHEMIA

Tuesday, November 18th, 2014 | Healthcare

CHROMATIN INC. APPOINTS TROY RANDOLPH AS CHIEF FINANCIAL OFFICER

Thursday, November 13th, 2014 | Clean Tech

RESHAPE MEDICAL UNVEILS US PIVOTAL TRIAL RESULTS FOR NON-SURGICAL WEIGHT LOSS PROCEDURE FEATURED IN TOP 10 PAPER AT OBESITY WEEK 2014

Tuesday, November 4th, 2014 | Healthcare

VIRENT: THE NEW ALCHEMY? COMPANY MAKES JET FUEL AND PLASTIC SODA BOTTLES OUT OF FARM WASTES

Tuesday, November 4th, 2014 | Clean Tech

VIRENT AND THE PLANTPET TECHNOLOGY COLLABORATIVE (PTC) SIGN EXPRESSION OF INTEREST TO ACCESS COMMERCIAL QUANTITIES OF VIRENT’S BIOFORMPX PARAXYLENE

Thursday, October 30th, 2014 | Clean Tech

CHROMATIN, INC. RECEIVES GOVERNOR’S EXPORT AWARD

Tuesday, October 28th, 2014 | Clean Tech

JUVENTAS THERAPEUTICS STRENGTHENS MANAGEMENT TEAM WITH NEW SENIOR VICE PRESIDENT OF FINANCE AND OPERATIONS

Tuesday, October 28th, 2014 | Healthcare

AKEBIA ANNOUNCES POSITIVE TOP-LINE RESULTS FROM ITS PHASE 2B STUDY OF AKB-6548 IN NON-DIALYSIS PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE

Monday, October 27th, 2014 | Healthcare

VENTURE INVESTORS FOUNDER ROGER GANSER ELECTED TO STATE’S INVESTOR HALL OF FAME

Wednesday, October 22nd, 2014 | Venture Investors

NEUWAVE MEDICAL CORRALS $4.8M FOR TUMOR-ZAPPING TECH

Wednesday, October 15th, 2014 | Healthcare

DELTANOID’S DP001 (2MD) PHARMACEUTICAL DEMONSTRATED SAFE AND EFFECTIVE IN KIDNEY FAILURE PATIENTS ON DIALYSIS

Tuesday, October 14th, 2014 | Healthcare

NANOBIO TO PRESENT DATA DEMONSTRATING THE POTENTIAL FOR ITS INTRANASAL VACCINE TO PROTECT AGAINST GENITAL HERPES INFECTION

Wednesday, October 8th, 2014 | Healthcare

HISTOSONICS: BLAZING NEW TRAILS IN MEDICINE

Tuesday, October 7th, 2014 | Healthcare

RESHAPE MEDICAL – 2014 FIERCE 15

Wednesday, October 1st, 2014 | Healthcare

VIRENT HIRES EDGAR STEENWINKEL TO LEAD TECHNOLOGY DEVELOPMENT EFFORTS

Tuesday, September 30th, 2014 | Clean Tech

THALCHEMY: A “SMART” MOVE FOR ELECTRONICS

Saturday, September 27th, 2014 | Technology

AKEBIA ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 STUDY OF AKB-6548 IN PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS

Thursday, September 25th, 2014 | Healthcare

ALFALIGHT RECEIVES $3.7M CONTRACT TO DELIVER TECHNOLOGY FOR THAAD MISSILE DEFENSE SYSTEM

Tuesday, September 23rd, 2014 | Technology

TISSUE REGENERATION SYSTEMS: STARTUP USES 3D PRINTING TECH TO CREATE ALTERNATIVE TO BONE GRAFTS

Tuesday, September 16th, 2014 | Healthcare

AKEBIA THERAPEUTICS APPOINTS RONALD C. RENAUD JR. TO ITS BOARD OF DIRECTORS

Monday, September 15th, 2014 | Healthcare

VIRENT TO EXPAND DEMO PLANT CAPABILITIES TO SCALE PLANT-BASED PARAXYLENE

Monday, September 8th, 2014 | Clean Tech

CELLECTAR & MVI: TWO MADISON BIOTECHS TO ADVANCE WITH DRUG TRIALS; A MEDICAL DEVICE COMPANY RECEIVES FUNDS

Saturday, September 6th, 2014 | Healthcare

CELLECTAR BIOSCIENCES ANNOUNCES ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION TO EVALUATE I-131-CLR1404 IN CLINICAL TRIALS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Thursday, September 4th, 2014 | Healthcare

AERPIO THERAPEUTICS ANNOUNCES PUBLICATION OF PRECLINICAL DATA ON AKB-9778 FOR COMMON EYE DISEASES

Tuesday, September 2nd, 2014 | Healthcare

RESHAPE MEDICAL ANNOUNCES NEW DATA SHOWING CLINICALLY SIGNIFICANT WEIGHT LOSS WITH THE RESHAPE PROCEDURE IN EU COMMERCIAL USE

Thursday, August 28th, 2014 | Healthcare

RESHAPE TARGETS U.S. APPROVAL AS EU STUDY SHOWS MAJOR WEIGHT LOSS

Thursday, August 28th, 2014 | Healthcare

MVI VACCINE TO BE USED IN CLINICAL TRIAL OF A NEW COMBINATION APPROACH TO IMMUNOTHERAPY FUNDED BY THE PROSTATE CANCER FOUNDATION AND THE MOVEMBER FOUNDATION

Wednesday, August 27th, 2014 | Healthcare

TISSUE REGENERATION SYSTEMS NABS $4.6M TO IMPROVE FACIAL SURGERIES

Friday, August 22nd, 2014 | Healthcare

TISSUE REGENERATION SYSTEMS TO COLLABORATE WITH J&J, DEPUY SYNTHES

Thursday, August 21st, 2014 | Healthcare